Quoin Pharmaceuticals. Ltd Sponsored ADR QNRX 深 沪
等待开盘 06-25 09:30:00 美东时间
3.83
+0.580
+17.85%
华盛通- 最 高4.98
- 今 开4.27
- 成交量 857.89万股
- 最 低 3.63
- 昨 收 3.25
- 总市值 769.22万
- 52周最高 41.80
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 3.25
- 委 比 97.28%
- 总股本 200.84万
- 历史最高 1417500.00
- 量 比 11.30
- 振 幅 41.54%
- 历史最低 3.25
- 每 手 1
- 风险率 3.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Shares of Leifras Co Ltd (NASDAQ:LFS) rose sharply in pre-market trading after the company announced it will acquire SWIFT JAPAN for around JPY454.6 million. Leifras shares jumped 23.2% to $2.76 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Megan Holdings Lt...
06-24 16:44
美股夜盘 | Quoin Pharmaceuticals. Ltd Sponsored ADR涨58.15%，LEIFRAS Co涨29.02%
智能充电涨-29.45%；Rubico Inc.涨-15.73%；Cerebras Systems涨-11.98%
06-24 08:05
Quoin Pharmaceuticals Receives FDA's Conditional Approval For QYLEKI To Treat Netherton Syndrome
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) ("Quoin" or the "Company"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved QYLEKI™ as the proposed brand name for QRX003, ...
06-23 20:31
Quoin Pharmaceuticals Pharmaceuticals Submits Investigational New Drug Application To FDA For Phase II Trial Of Peeling Skin Syndrome Treatment QRX003
The IND submission is supported by clinical observations from Quoin's ongoing investigator-led pediatric PSS study. The initial subject has been treated with QRX003 for over 15 months and significant clinical
06-02 20:36
Quoin Pharmaceuticals Q1 EPS $(1.77) Misses $(1.72) Estimate
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.72) by 2.91 percent. This is a 72.77 percent increase over losses of $(6.50) per share
05-07 20:32
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
LUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30
LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $30.
05-05 01:04
美股夜盘 | Kingswood Acquisition Corp. Class A涨59.20%，Enterprise Financial Services Corp Depositary Shs Repr 1/40th 5 % Non-Cum Red Perp Pfd Shs Series A涨27.12%
Kingswood Acquisition Corp. Class A涨59.20%；Enterprise Financial Services Corp Depositary Shs Repr 1/40th 5 % Non-Cum Red Perp Pfd Shs Series A涨27.12%；PMGC Holdings Inc.涨26.54%
04-01 13:01
美股夜盘 | 优品车涨40.80%，Globavend Holdings Ltd.涨40.78%
优品车涨40.80%；Globavend Holdings Ltd.涨40.78%；BeLive Holdings涨14.67%
03-27 15:01
美股夜盘 | 优品车涨45.22%，Globavend Holdings Ltd.涨42.72%
优品车涨45.22%；Globavend Holdings Ltd.涨42.72%；Turbo Energy涨12.76%
03-27 13:01
